Loading…
Supriya Lifescience (SUPRIYA)₹631.25−3.03%Pharmaceuticals
At the end of the Jun 2026 quarter, Supriya Lifescience's shareholders were: promoters 68.29%, FIIs 6.24%, DIIs 5.27%, public 20.20%. Promoter holding is unchanged on the quarter. FII holding is down 0.60 percentage points from 6.84% a year earlier. 0.00% of promoter shares were pledged. It had 82,068 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68.29% | 68.29% | 68.29% | 68.29% | 68.29% | 68.29% | 68.29% | 68.29% | 68.29% | 68.29% | 68.29% | 68.29% |
| FIIs | 5.40% | 4.60% | 5.42% | 5.00% | 6.09% | 6.58% | 7.25% | 6.84% | 5.51% | 5.24% | 5.21% | 6.24% |
| DIIs | 7.13% | 5.35% | 5.27% | 5.44% | 5.41% | 4.90% | 4.23% | 4.83% | 5.19% | 4.97% | 5.66% | 5.27% |
| Public | 19.18% | 21.76% | 21.02% | 21.27% | 20.21% | 20.23% | 20.23% | 20.04% | 21.01% | 21.50% | 20.84% | 20.20% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 92,975 | 95,913 | 87,965 | 89,606 | 85,314 | 89,379 | 91,036 | 91,913 | 87,897 | 85,085 | 81,147 | 82,068 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Satish Waman Wagh | Promoter | 67.66% | 0.00 |
| Cohesion Mk Best Ideas Sub-Trust | FII | 2.96% | 0.00 |
| Aditya Birla Sun Life Insurance Company Limited | DII | 2.17% | +0.05 |
| Smita Satish Wagh | Promoter | 0.40% | 0.00 |
| Saloni Satish Wagh | Promoter | 0.13% | 0.00 |
| Shivani Satish Wagh | Promoter | 0.13% | 0.00 |
Promoters held 68.29% of Supriya Lifescience at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 6.24% (up 1.03 percentage points from 5.21% a quarter earlier) and domestic institutions (DIIs) held 5.27% (down 0.39 percentage points from 5.66% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Supriya Lifescience had 82,068 shareholders at the end of the Jun 2026 quarter, against 91,913 a year earlier.
Cohesion Mk Best Ideas Sub-Trust (FII) held 2.96% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.